Dong‐Bing Cheng

2.4k total citations · 1 hit paper
49 papers, 2.0k citations indexed

About

Dong‐Bing Cheng is a scholar working on Biomedical Engineering, Biomaterials and Molecular Biology. According to data from OpenAlex, Dong‐Bing Cheng has authored 49 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Biomedical Engineering, 21 papers in Biomaterials and 20 papers in Molecular Biology. Recurrent topics in Dong‐Bing Cheng's work include Nanoplatforms for cancer theranostics (27 papers), Nanoparticle-Based Drug Delivery (17 papers) and RNA Interference and Gene Delivery (9 papers). Dong‐Bing Cheng is often cited by papers focused on Nanoplatforms for cancer theranostics (27 papers), Nanoparticle-Based Drug Delivery (17 papers) and RNA Interference and Gene Delivery (9 papers). Dong‐Bing Cheng collaborates with scholars based in China, United Kingdom and Japan. Dong‐Bing Cheng's co-authors include Hao Wang, Zeng‐Ying Qiao, Yujuan Gao, Lei Ji, Xuehao Zhang, Yong Cong, Dong Wang, Da‐Yong Hou, Lijuan Niu and Feng Bai and has published in prestigious journals such as Journal of the American Chemical Society, Chemical Society Reviews and Advanced Materials.

In The Last Decade

Dong‐Bing Cheng

46 papers receiving 2.0k citations

Hit Papers

In vivo assembly enhanced binding effect augments tumor s... 2024 2026 2025 2024 20 40 60

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dong‐Bing Cheng China 22 1.1k 882 815 595 221 49 2.0k
Si‐Yong Qin China 28 1.3k 1.2× 1.2k 1.4× 1.2k 1.4× 666 1.1× 375 1.7× 82 2.8k
Mingzhou Ye China 17 862 0.8× 425 0.5× 619 0.8× 388 0.7× 148 0.7× 26 1.6k
Chunhua Ren China 31 1.0k 0.9× 1.4k 1.6× 1.2k 1.5× 601 1.0× 505 2.3× 67 2.7k
Wenjun Zhan China 25 938 0.8× 589 0.7× 631 0.8× 495 0.8× 469 2.1× 61 1.9k
Hong‐Wei An China 31 1.0k 0.9× 958 1.1× 1.2k 1.5× 409 0.7× 365 1.7× 69 2.5k
Yongyan Deng China 18 1.5k 1.3× 563 0.6× 664 0.8× 703 1.2× 297 1.3× 26 2.2k
Chunqiu Zhang China 26 849 0.7× 969 1.1× 1.0k 1.3× 1.1k 1.9× 397 1.8× 75 2.6k
Yin‐Jia Cheng China 17 796 0.7× 663 0.8× 532 0.7× 348 0.6× 133 0.6× 46 1.4k
Ya‐Xuan Zhu China 33 2.0k 1.7× 739 0.8× 942 1.2× 1.2k 2.1× 182 0.8× 68 3.1k
Kaimin Cai United States 17 1.2k 1.0× 1.0k 1.2× 819 1.0× 390 0.7× 297 1.3× 25 2.1k

Countries citing papers authored by Dong‐Bing Cheng

Since Specialization
Citations

This map shows the geographic impact of Dong‐Bing Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dong‐Bing Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dong‐Bing Cheng more than expected).

Fields of papers citing papers by Dong‐Bing Cheng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dong‐Bing Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dong‐Bing Cheng. The network helps show where Dong‐Bing Cheng may publish in the future.

Co-authorship network of co-authors of Dong‐Bing Cheng

This figure shows the co-authorship network connecting the top 25 collaborators of Dong‐Bing Cheng. A scholar is included among the top collaborators of Dong‐Bing Cheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dong‐Bing Cheng. Dong‐Bing Cheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Lu, Silin Chen, Xinyi Guo, et al.. (2025). Recent advancements in the design and application of Thioctic acid-based self-assembled materials. Coordination Chemistry Reviews. 537. 216679–216679. 3 indexed citations
2.
Hou, Da‐Yong, et al.. (2025). Intracellular aggregation of exogenous molecules for biomedical applications. Chemical Society Reviews. 54(13). 6412–6447. 5 indexed citations
3.
Lei, Zhixin, et al.. (2025). Neuraminidase and pH responsive nano-drug against resistant Glaesserella parasuis. International Journal of Biological Macromolecules. 303. 140633–140633.
4.
Zhu, Chunnan, et al.. (2025). In Situ Self‐Assembly Enhanced Cavitation for Efficient Sonodynamic Therapy of Tumors. Advanced Healthcare Materials. 14(22). e2501655–e2501655.
5.
Hou, Da‐Yong, et al.. (2024). Strategy and Design of In Situ Activated Protein Hydrolysis Targeted Chimeras. ACS Nano. 19(1). 101–119. 6 indexed citations
6.
Hou, Da‐Yong, Lu Wang, Xiangpeng Li, et al.. (2024). Inducing mitochondriopathy-like damages by transformable nucleopeptide nanoparticles for targeted therapy of bladder cancer. National Science Review. 11(4). nwae028–nwae028. 12 indexed citations
7.
Hou, Da‐Yong, Dong‐Bing Cheng, Zhijia Wang, et al.. (2024). In vivo assembly enhanced binding effect augments tumor specific ferroptosis therapy. Nature Communications. 15(1). 454–454. 67 indexed citations breakdown →
8.
Zhang, Xuehao, Ningbo Yi, Guangxu Zhang, et al.. (2024). Programmable Morphology‐Adaptive Peptide Nanoassembly for Enhanced Catalytic Therapy. Advanced Materials. 37(6). e2417089–e2417089. 11 indexed citations
9.
Hou, Da‐Yong, Qing You, Xiangpeng Li, et al.. (2024). Cascade-Activatable Nanoprodrug System Augments Sonochemotherapy of Bladder Cancer. ACS Nano. 18(52). 35507–35519. 7 indexed citations
10.
Zhu, Chunnan, Xin Chen, Fei Wang, et al.. (2024). Advanced Preparation Methods and Biomedical Applications of Single-Atom Nanozymes. ACS Biomaterials Science & Engineering. 10(12). 7352–7371. 6 indexed citations
11.
Jin, Peng, Dongyun Zheng, Chao Liu, et al.. (2023). Cu-In-S/ZnS:Gd3+ quantum dots with isolated fluorescent and paramagnetic modules for dual-modality imaging in vivo. Colloids and Surfaces B Biointerfaces. 223. 113158–113158. 4 indexed citations
12.
Xu, Xiaoxue, Ningbo Yi, Xin Li, et al.. (2022). Research progress on tumor hypoxia-associative nanomedicine. Journal of Controlled Release. 350. 829–840. 63 indexed citations
13.
Zhu, Chunnan, Fei Song, Dongyun Zheng, et al.. (2022). Reversible covalent nanoassemblies for augmented nuclear drug translocation in drug resistance tumor. Journal of Controlled Release. 353. 186–195. 8 indexed citations
14.
Xiao, Wuyi, et al.. (2022). In situ self-assembled peptide enables effective cancer immunotherapy by blockage of CD47. Colloids and Surfaces B Biointerfaces. 217. 112655–112655. 20 indexed citations
15.
Yang, Pei‐Pei, Kuo Zhang, Pingping He, et al.. (2020). A biomimetic platelet based on assembling peptides initiates artificial coagulation. Science Advances. 6(22). eaaz4107–eaaz4107. 79 indexed citations
16.
Cheng, Dong‐Bing, Xuehao Zhang, Yuanfang Chen, et al.. (2020). Ultrasound-Activated Cascade Effect for Synergistic Orthotopic Pancreatic Cancer Therapy. iScience. 23(6). 101144–101144. 28 indexed citations
17.
Wang, Dong, Dong‐Bing Cheng, Lei Ji, et al.. (2020). Precise magnetic resonance imaging-guided sonodynamic therapy for drug-resistant bacterial deep infection. Biomaterials. 264. 120386–120386. 103 indexed citations
18.
Cheng, Dong‐Bing, Guobin Qi, Jingqi Wang, et al.. (2017). In Situ Monitoring Intracellular Structural Change of Nanovehicles through Photoacoustic Signals Based on Phenylboronate-Linked RGD-Dextran/Purpurin 18 Conjugates. Biomacromolecules. 18(4). 1249–1258. 36 indexed citations
19.
Cheng, Yin‐Jia, Xuan Zeng, Dong‐Bing Cheng, et al.. (2016). Functional mesoporous silica nanoparticles (MSNs) for highly controllable drug release and synergistic therapy. Colloids and Surfaces B Biointerfaces. 145. 217–225. 29 indexed citations
20.
Cheng, Dong‐Bing, Kei Hashimoto, & Yasushi Uda. (2003). In vitro digestion of sinigrin and glucotropaeolin by single strains of Bifidobacterium and identification of the digestive products. Food and Chemical Toxicology. 42(3). 351–357. 94 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026